Co-Dx announced a massive jump in first quarter revenues due in large part to strong sales of its Logix Smart COVID-19 test for SARS-CoV-2, recording a 13-fold increase year over year. Sales of the PCR-based test surged thanks to Emergency Use Authorization from the U.S. Food and Drug Administration.
Read the article here:
https://www.genomeweb.com/molecular-diagnostics/co-diagnostics-posts-q1-revenue-boost-sars-cov-2-test-sales